US Patent 9296761 Triazine derivatives
Patent 9296761 was granted and assigned to Pfizer Limited on March, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Dec, 2023
Golden AI
Edits made to:
Article (+228 characters)
Article
Patent abstract
The present invention is directed to a new class of triazine derivatives as described by formula I below in which A, X, R1, R2, R3, and R4 are as defined herein and to the use of the compounds as PDE10 inhibitors.
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Bethany Lyn Kormos0
Christopher John Helal0
Jamison Bryce Tuttle0
Patrick Robert Verhoest0
Thomas Allen Chappie0
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09296761 Triazine derivatives US Patent 9296761 Triazine derivatives
Infobox
Patent Number
092967610
Patent Number
92967610
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
092967610
Date of Patent
March 29, 2016
0Patent Application Number
148298420
Date Filed
August 19, 2015
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09296761 Triazine derivatives
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09296761
Date of patent
March 29, 2016
Patent application number
14829842
Date Filed
August 19, 2015
Patent primary examiner
Find more entities like US Patent 9296761 Triazine derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
